期刊文献+

儿科药品临床研究立项与试验设计策略分析 被引量:2

Strategies of the initiation and design of paediatric drug trials
原文传递
导出
摘要 儿科药品临床研究是完善儿科用药信息的有效途径之一。鉴于目前市场上儿科用药信息普遍缺乏,需要根据临床需求的迫切程度,选择优先关注领域,逐步完善,因此,前期立项依据尤为重要。本文引用国外该领域研究发现及成果,结合相关实例,对儿科临床研究试验设计桥接研究、不同年龄段特殊性、标本的采集与使用、对照组选择、知情同意、评估的终点指标等进行考虑,旨在为同行提供参考。 Clinical research of pediatric drugs is one of the effective ways to improve children's medication information. In view of the lack of medication information for children, we should improve it gradually according to clinical demand and the priority areas of concern. Thus the prophase of the project is particularly important. Refer- enced to new founds and achievements in this field of foreign countries and combined some examples, this review focuses on some considerations for the design of pediatric drug trials, such as initiating a project basis, risk and benefit, bridging research, the particularity of different ages, specimen collection and use, the selection of control group, inform and consent, assessment of endpoint, and so on The review maybe offer help for peers.
出处 《中国新药杂志》 CAS CSCD 北大核心 2015年第10期1145-1149,共5页 Chinese Journal of New Drugs
关键词 儿科临床研究 立项依据 风险与受益 桥接研究 标本 对照组 paediatric clinical trials project basis risk and benefit bridging research specimen con-trol group
  • 相关文献

参考文献22

  • 1卢耀文,孙天宇,邓桂兴,蔺荣,林松,王霆.儿科药物临床试验国内外相关法规解读与思考[J].中国新药杂志,2013,22(3):256-259. 被引量:12
  • 2世界卫生组织/有关儿科卫生的实况报道/肺炎[EB/OL].(2013-11)[2015-01-12].http://www.who.int/mediacen-tre/factsheets/fs331/zh/.
  • 3BPCA. Clinical Studies [ EB/OL ]. (2012 - 03 - 26 ) [ 2015 - 01 - 12 ]. http ://bpca. nichd.nih. gov/elinical/Pages/index, aspx.
  • 4EU. Ethical considerations for clinical trials on medicinal prod- ucts conducted in the paediatric population. Recommendations of the ad hoe group for the development of implementing guidelines for Directive 2001/20/EC relating to good clinical practice in the conduct of clinical trials on medicinal products for human use [ E B/OL ]. (2001) [ 2014 - 5 - 20 ]. http ://ec. europa, eu/en- terprise/pharnaaceutieals/eudralex/vol-10/ethieal _ considera- tions, pdf.
  • 5周海钧.药品注册的国际技术要求[M].北京:人民卫生出版社,2011:4-12.
  • 6US. National Institutes of Health. Efficacy of Single-Shot Dexme- detomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery [ EB/OL]. ( 2014 - 08 - 25 ) [2014 - 08 - 27 ]. http://clinicahrials, gov/ct2/show/ NCT01901588 ? term = paediatric&rank = 58.
  • 7US. National Institutes of Health. Safety of Two Doses of Avaxim 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents[ EB/OL]. (2014 - 08 - 25 ) [ 2014 - 08 - 27 ]. http ://clinicahrials. gov/ct2/show/NCT02011763 ? term = paediatric&rank = 15.
  • 8卢耀文,谭波,王霆.儿童临床研究项目伦理审查关键点[J].中国新药与临床杂志,2014,33(10):703-707. 被引量:12
  • 9BIROS MH, LEWIS RJ, OLSON CM, et al. Informed consent inemergency research: consensus statement from the Coalition Con- ference of Acute Resuscitation and Critical Care Researchers[J]. JAMA ,1995,273(16) :1283 - 1287.
  • 10SALZMAN JG, FRASCONE RJ, GODDING BK, et al. Imple- menting emergency research requiring exception from informed consent, community consultation, and public disclosure[ J]. Ann Emerg Med ,2007,50 (4) :448 - 455.

二级参考文献10

  • 1季成叶.儿童少年卫生学[M].7版.北京:人民卫生出版社,2012:20-25.
  • 2FDA.Guidance for IRBs,clinical Investigators,and Sponsors,IRB Continuing Review after Clinical Investigation Approval[EB/OL].(2012-02)[2014-04-20].http://www.fda.gov/downloads/regulatoryinformation/guidances/ucm294558.pdf.
  • 3国家食品药品监督管理局.药物临床试验机构名单,儿科[EB/OL].[2013-04-09].http://app1.sfda.gov.cn/datasearch/face3/base.jsp?table Id=19&table Name=TABLE19&title=药物临床试验机构名单&bc Id=118714941832181502104731901420.
  • 4MRC funded researchers.Medical research involving children[EB/OL].(2007-08-24)[2014-04-25].http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC002430.
  • 5UN.UN Convention on the Rights of the Child.General Assembly resolution 44/25 of 20 November 1989,entry into force 2September 1990 in accordance with article 49[EB/OL].(1989-11-20)[2014-04-20].http://www.unicef.org/chinese/crc/.
  • 6丘祥兴,孙福川,王明旭.医学伦理学[M].4版.北京:人民卫生出版社,2013:186-191.
  • 7中华人民共和国.中华人民共和国民法通则[EB/OL].(1986-04-12)[2014-04-25].http://baike.so.com/doc/2720327.html.
  • 8杨志敏,赵德恒.建立新药儿科临床试验管理体系的探讨[J].中国临床药理学杂志,2009,25(6):547-549. 被引量:6
  • 9赵维,Evelyne Jacqz-Aigrain.法国儿科临床研究中心网络:欧洲合作计划新视点(英文)[J].儿科药学杂志,2011,17(1):1-5. 被引量:3
  • 10卢耀文,孙天宇,邓桂兴,蔺荣,林松,王霆.儿科药物临床试验国内外相关法规解读与思考[J].中国新药杂志,2013,22(3):256-259. 被引量:12

共引文献19

同被引文献38

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部